The potential long-term comparative effectiveness of larotrectinib versus regorafenib or trifluridine/tipiracil for treatment of metastatic TRK fusion colorectal cancer

被引：0
|
作者：
Suh, Kangho
Carlson, Josh John
Xia, Fang
Williamson, Todd E.
Sullivan, Sean D.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
41
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Long-term efficacy and safety of larotrectinib in patients with TRK fusion lung cancer.
    Drilon, Alexander E.
    Kummar, Shivaani
    Lin, Jessica Jiyeong
    Tan, Daniel Shao-Weng
    Moreno, Victor
    Leyvraz, Serge
    Dubashi, Biswajit
    Haresh, K. P.
    Burcoveanu, Domnita-Ileana
    Neu, Natascha
    Mussi, Chiara E.
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer
    Leyvraz, S.
    Hong, D. S.
    Shen, L.
    van Tilburg, C. M.
    Tan, D. S. W.
    Kummar, S.
    Lin, J. J.
    Doz, F.
    McDermott, R.
    Albert, C. M.
    Berlin, J.
    Bielack, S.
    Lassen, U. N.
    Tahara, M.
    Norenberg, R.
    Shurshalina, A.
    Fellous, M.
    Nogai, H.
    Xu, R.
    Laetsch, T. W.
    Drilon, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 13 - 13
  • [33] An Observational Study of Trifluridine/Tipiracil-Containing Regimen Versus Regorafenib-Containing Regimen in Patients With Metastatic Colorectal Cancer
    Hsieh, Meng-Che
    Rau, Kun-Ming
    Lin, Shung-Eing
    Liu, Kuang-Wen
    Chiu, Chong-Chi
    Chen, Chih-, I
    Song, Ling-Chiao
    Chen, Hsin-Pao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] A real-world comparison of trifluridine/tipiracil and regorafenib in refractory metastatic colorectal cancer in the United States
    Nevala-Plagemann, Christopher Duane
    Ying, Jian
    Sama, Shashank
    Florou, Vaia
    Haaland, Benjamin
    Garrido-Laguna, Ignacio
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [35] Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: A retrospective study
    Li, Rongrong
    Zhou, Hui-Jun
    Zeng, De-Yu
    Jiang, Shao-Feng
    Liu, Wu
    Liu, Zhen-yang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United States
    Nevala-Plagemann, Christopher
    Sama, Shashank
    Ying, Jian
    Shen, Jincheng
    Haaland, Benjamin
    Florou, Vaia
    Garrido-Laguna, Ignacio
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (03): : 257 - 264
  • [37] Real-World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib
    Patel, Anuj K.
    Barghout, Victoria
    Yenikomshian, Mihran A.
    Germain, Guillaume
    Jacques, Philippe
    Laliberte, Francois
    Duh, Mei S.
    ONCOLOGIST, 2020, 25 (01): : E75 - E84
  • [38] Phase I/II study of trifluridine/tipiracil plus XB2001 versus trifluridine/tipiracil in metastatic colorectal cancer
    Fumet, Jean-David
    Roussot, Nicolas
    Bertaut, Aurelie
    Limagne, Emeric
    Thibaudin, Marion
    Hervieu, Alice
    Zanetta, Sylvie
    Borg, Christophe
    Senellart, Helene
    Pernot, Simon
    Thuillier, Frederic
    Carnot, Aurelien
    Mineur, Laurent
    Chibaudel, Benoist
    Touchefeu, Yann
    Martin-Babau, Jerome
    Jary, Marine
    Labourey, Jean-Luc
    Rederstorff, Emilie
    Lepage, Come
    Ghiringhelli, Francois
    FUTURE ONCOLOGY, 2024, 20 (38) : 3077 - 3085
  • [39] Effectiveness and Safety of Regorafenib vs. Trifluridine/Tipiracil in Unresectable Colorectal Cancer: A Retrospective Cohort Study
    Nakashima, Masayuki
    Takeuchi, Masato
    Kawakami, Koji
    CLINICAL COLORECTAL CANCER, 2020, 19 (04) : E208 - E225
  • [40] Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
    Kotani, Daisuke
    Kuboki, Yasutoshi
    Horasawa, Satoshi
    Kaneko, Asumi
    Nakamura, Yoshiaki
    Kawazoe, Akihito
    Bando, Hideaki
    Taniguchi, Hiroya
    Shitara, Kohei
    Kojima, Takashi
    Tsuji, Akihito
    Yoshino, Takayuki
    BMC CANCER, 2019, 19 (01)
12345